Literature DB >> 6404595

Fertility regulation in nursing women: III. Short-term influence of a low-dose combined oral contraceptive upon lactation and infant growth.

S Díaz, O Peralta, G Juez, C Herreros, M E Casado, A M Salvatierra, P Miranda, E Durán, H B Croxatto.   

Abstract

The study was designed to test the short-term influence of a low-dose combined oral contraceptive upon lactation and infant growth when treatment was initiated at day 30 postpartum. The contraceptive tested contained ethinyl estradiol 0.03 mg and levonorgestrel 0.15 mg. Two control groups were formed by women who received either an oral placebo or an injectable placebo at day 30 postpartum. An exacting list of requirements for admission and continuation in the study was applied to all groups. The oral contraceptive group had a lower percentage of cases in exclusive breastfeeding at day 91 postpartum when compared to both control groups. Infants in the oral contraceptive group showed a significantly lower average absolute weight at days 61 and 91 postpartum and a significantly lower average daily weight increase during the first month of treatment when compared to both control groups. It was concluded that the oral contraceptive tested had a negative influence upon lactation and child growth.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6404595     DOI: 10.1016/0010-7824(83)90051-3

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  2 in total

1.  Effect of progestin compared with combined oral contraceptive pills on lactation: a randomized controlled trial.

Authors:  Eve Espey; Tony Ogburn; Lawrence Leeman; Rameet Singh; Katie Ostrom; Ronald Schrader
Journal:  Obstet Gynecol       Date:  2012-01       Impact factor: 7.661

Review 2.  Hormonal Contraceptives and Mood: Review of the Literature and Implications for Future Research.

Authors:  Thalia Robakis; Katherine E Williams; Lexi Nutkiewicz; Natalie L Rasgon
Journal:  Curr Psychiatry Rep       Date:  2019-06-06       Impact factor: 5.285

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.